Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_04446
Species: Homo sapiens
Position : chr2:136531405-136531505
Year: 2011
Title: The -14010*C variant associated with lactase persistence is located between an Oct-1 and HNF1汐 binding site and increases lactase promoter activity.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Normal
PMID:  21327791
Cell Source: Caco-2
CVCL ID: CVCL_0025
Experiment Type: Enhancer activity assay; TF-binding/chromatin assay
Low Throughput Method: Luciferase reporter assay; Reporter assay; EMSA/gel-shift assay
About Target Gene
Target gene : LCT
About TF
TF name : POU2F1
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
POU2F1 AndrogenReceptor netpath 167
POU2F1 ATF-2 transcription factor network pid 59
POU2F1 Calcineurin-regulated NFAT-dependent transcription in lymphocytes pid 50
POU2F1 Calcium signaling in the CD4+ TCR pathway pid 29
POU2F1 FOXA1 transcription factor network pid 45
POU2F1 Glucocorticoid receptor regulatory network pid 85
POU2F1 Regulation of Androgen receptor activity pid 54
POU2F1 RNA polymerase II transcribes snRNA genes reactome 70
POU2F1 RNA Polymerase III Abortive And Retractive Initiation reactome 41
POU2F1 RNA Polymerase III Transcription Initiation From Type 3 Promoter reactome 28
POU2F1 Hs_Integrated_Cancer_Pathway_WP1971_82939 wikipathways 33
Enhancer Associated Network
Overlapping Enhancers (hg19) 1 found
Enhancer ID Position Tissue Cell Disease
E_04445 chr2:136531405-136531505 NA NA NA
Expression of Target Genes for the Enhancer